Are You Looking for a Top Momentum Pick? Why I-Mab Sponsored ADR (IMAB) is a Great Choice

Company Overview - I-Mab Sponsored ADR (IMAB) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook compared to the market [3] Price Performance - IMAB shares have increased by 4.52% over the past week, outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 0.67% [5] - Over the past month, IMAB's price change is 121.68%, significantly higher than the industry's 0.85% performance [5] - In the last quarter, IMAB shares have surged by 151.4%, and over the past year, they have gained 284.61%, while the S&P 500 has only moved 9.72% and 16.49% respectively [6] Trading Volume - The average 20-day trading volume for IMAB is 4,790,854 shares, which is a useful indicator of market interest and momentum [7] Earnings Outlook - In the past two months, one earnings estimate for IMAB has moved higher, while none have moved lower, resulting in an increase in the consensus estimate from -$0.44 to -$0.41 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [9] Conclusion - Given the strong price performance, positive earnings outlook, and high momentum score, IMAB is positioned as a solid momentum pick for investors [11]